Optimizing Ex-Vivo Expanded NK Cell- Mediated Cellular Cytotoxicity By Obinutuzumab Combined with NKTR-255 in Burkitt Lymphoma (BL)
Author Type(s)
Faculty, Resident/Fellow
Document Type
Abstract
Publication Date
11-2023
DOI
10.1182/blood-2023-181996
Journal Title
Blood
Department
Pediatrics
Recommended Citation
Chu, Y., Foley, K., Tian, M., Klose, K., Ayala-Cuesta, J., Lee, D. A., Marcondes, M., Klein, C., & Cairo, M. S. (2023). Optimizing Ex-Vivo Expanded NK Cell- Mediated Cellular Cytotoxicity By Obinutuzumab Combined with NKTR-255 in Burkitt Lymphoma (BL). Blood, 142 (Suppl. 1), 2063. https://doi.org/10.1182/blood-2023-181996
COinS
